Print version ISSN 0100-8358
PROCOPIO, S.O. et al. Potential use of chlorimuron-ethyl, imazethapyr and cloransulam-methyl in common bean crop. Planta daninha [online]. 2009, vol.27, n.2, pp. 327-336. ISSN 0100-8358. http://dx.doi.org/10.1590/S0100-83582009000200016.
This study aimed to evaluate the selectivity of the herbicides chlorimuron-ethyl, imazethapyr and cloransulam-methyl when applied in association with fomesafen on ten common bean cultivars. The experiment was carried out in Rio Verde-Goias during the growing season of 2005/2006, in a completely randomized block design, with three replicates, in split-plots. The herbicide treatments [fomesafen (225 g ha-1 ), fomesafen (225 g ha-1 ) + chlorimuron-ethyl (7.5 g ha-1 ), fomesafen (225 g ha-1 ) + imazethapyr (50 g ha-1 ), fomesafen (225 g ha-1 ) + cloransulam-methyl (30.24 g ha-1 ), and control without herbicide] were tested in the plots and the cultivars (BRS Grafite, BRS Horizonte, Pérola, BRS Pitanga, BRS Pontal, BRS Requinte, BRS Supremo, BRS Timbó, BRS Valente and BRS Vereda), in the split-plots. The plots were kept hoed to avoid weed interference. All treatments caused phytotoxicity to the cultivars, but the treatment with chlorimuron-ethyl showed more severe symptoms. This same treatment also resulted in greater reduction of plant height, shoot dry matter and an extended maturation cycle. The sole application of fomesafen caused a decrease in grain productivity of BRS Timbó, and BRS Vereda. When fomesafen was applied in a mixture with imazethapyr, a decrease in grain productivity was observed for the cultivars BRS Timbó, BRS Vereda, and BRS Supremo. Cloransulam-methyl addition led to a productivity reduction of these three cultivars and BRS Requinte, as well. The productivity of Pérola, BRS Pitanga, BRS Pontal, and BRS Valente cultivars was not affected by the application of chlorimuron-ethyl + fomesafen. Imazethapyr presented potential to be used in common bean crop.
Keywords : Phaseolus vulgaris; fomesafen; ALS inhibitors; sulfonylurea; imidazolinone.